Making sense of Marfan syndrome

July 14, 2002

In the July 15 issue of Genes & Development, Drs. Massimo Caputi, Raymond Kendzior Jr. and Karen Beemon of Johns Hopkins University report on their determination of a molecular mechanism of Marfan syndrome pathogenesis - a discovery that may end the decade-long debate over how this relatively common genetic disorder develops.

Originally characterized in 1896, Marfan syndrome is a heritable disorder of the connective tissue, which usually affects the skeletal, respiratory, cardiovascular, and ocular systems, and is commonly associated with tall stature and markedly long limbs. In 1991 scientists discovered that Marfan syndrome is caused by mutations in the fibrillin 1 (FBN1) gene.

Now, more than a decade later, Dr. Beemon and colleagues are lending new insight into the mechanism by which some mutations in the FBN1 gene result in Marfan syndrome.

The FBN1 gene encodes the fibrillin protein, a component of the rod-like microfibrils that comprise the connective tissue. Mutations in the FBN1 gene that compromise fibrillin protein activity can, in turn, affect the integrity of the connective tissue and give rise to the symptoms associated with Marfan syndrome.

The FBN1 gene has 65 exons, or coding regions, that are separated by non-coding introns, which are removed from, or "spliced out of," the pre-mRNA transcript during nuclear processing. In the early 1990s, a Marfan syndrome patient was found to harbor a mutation in FBN1 exon 51 that causes the nuclear splicing machinery to skip exon 51 entirely. Skipping exon 51 is problematic, though, as exon 51-skipped fibrillin proteins have compromised function because the region encoded by exon 51 is critical for normal fibrillin protein activity.

Dr. Beemon and colleagues demonstrate that exon 51 skipping is the result of the disruption of an exonic splicing enhancer (ESE), a DNA sequence within the FBN1 gene that increases splicing efficiency. The scientists discovered that other types of mutations that also disrupt the ESE can cause exon 51 skipping. The authors therefore conclude that FBN1 exon 51 skipping is dependent upon the disruption of an ESE.

Ultimately, this work helps further our understanding of the pathogenesis of Marfan syndrome, and possibly some of the other human diseases associated with exon skipping.
-end-


Cold Spring Harbor Laboratory

Related Mutations Articles from Brightsurf:

SARS-CoV-2 mutations do not appear to increase transmissibility
None of the mutations currently documented in the SARS-CoV-2 virus appear to increase its transmissibility in humans, according to a study led by UCL researchers, published in Nature Communications.

Predicting the evolution of genetic mutations
CSHL quantitative biologists have designed a new machine learning technique for predicting evolutionary pathways.

SNIPRs take aim at disease-related mutations
In a new study, lead author Alex Green, a researcher at the Biodesign Center for Molecular Design and Biomimetics and his colleagues describe a new method for detecting point mutations.

Cancer mutations occur decades before diagnosis
A large-scale pan-cancer analysis of the evolutionary history of tumours reveals that cancer-causing mutations occur decades before diagnosis.

Pinpointing rare disease mutations
Scientists have compiled mouse and human cell knockout data to categorise genes based on how essential they are for survival and organism development.

Using deep learning to predict disease-associated mutations
A research team led by Professor Hongzhe Sun from the Department of Chemistry at HKU, implemented a robust deep learning approach to predict disease-associated mutations of the metal-binding sites in a protein.

Cancer: The origin of genetic mutations
In the presence of some disruptive elements, cancer cells are unable to replicate its DNA optimally.

Mutations associated with sensitivity or resistance to immunotherapy in mNSCLC
The relationship between gene alterations and response to anti-PD-L1 with and without anti-CTLA-4 are not well characterized.

Machine learning for damaging mutations prediction
Scientists from Russia and India have proposed a novel machine-learning-based method for predicting damaging mutations in the protein atomic structure.

Discovery of new mutations may lead to better treatment
In the largest study to date on developmental delay, researchers analyzed genomic data from over 31,000 parent-child trios and found more than 45,000 de novo mutations, and 40 novel genes.

Read More: Mutations News and Mutations Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.